新型冠状病毒感染对婴儿癫痫性痉挛综合征患儿及家长的影响

Effects of COVID-19 pandemic on patients with infantile epileptic spasms syndrome and their parents

目的 通过在线问卷调查,评估新型冠状病毒(Coronavirus disease 2019,COVID-19)流行期间对婴儿癫痫性痉挛综合征患者以及家长的影响。方法 该研究为2022年5月—6月进行的横断面研究。调查问卷重点关注患者癫痫发作、就诊方面以及家长的心理健康评估。结果 共纳入67例婴儿癫痫性痉挛综合征患者。25.37%的患者出现痉挛发作增多。73.13%的患者购买抗癫痫发作药物困难,主要是氨己烯酸和氯巴占购买困难。全部患者均有就诊困难的情况,73.13%的患者选择远程医疗咨询。31.34%的家长感到焦虑,73.14%的家长有不同程度的抑郁症状。结论 COVID-19流行期间就诊困难、买药困难以及家长焦虑和抑郁状态,加重了婴儿癫痫性痉挛综合征患者的管理难度。健全医疗保健体系以及药品管理政策,合理的使用远程医疗资源可以更好的解决这一难题。

Objective To assess the effects of the Coronavirus disease 2019(COVID-19) epidemic on patients with infantile epileptic spasms syndrome and their parents through an online questionnaire survey. Methods This study was a cross-sectional study conducted from May to June 2022. The questionnaire focused on seizure attacks, medical visits, and the mental health assessment of parents. Results A total of 67 patients with infantile epileptic spasms syndrome were included in this study. During the epidemic, 25.37% of the patients experienced increased spasms, and 73.13% of the patients had limited commercial availability of anti-seizure medications, mainly vigabatrin and clobazam.All patients had difficulty seeking medical services, and about 73.13% of them used telemedicine service. In addition,31.34% of parents felt anxious, and 73.14% had different degrees of depressive symptoms. Conclusion The difficulty in seeking medical services, limited commercial availability of anti-seizure medications, and the anxiety and depressive states of parents during the COVID-19 pandemic aggravate the difficulty in management of patients with infantile epileptic spasms syndrome. Improvement of the health care system and medication management strategy, as well as reasonable use of telemedicine service, may help solve this problem.